New technology could improve surgical outcomes for cancer patients
A study led by researchers at RCSI's Department of Chemistry has the potential to help surgeons more accurately remove tumors and detect cancer in lymph nodes during surgery. The research, led by RCSI Professor...
New alliance will focus on the structural visualization of novel druggable sites
Jul 8 2019
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has entered into a structural biology focussed collaboration with the Centre for Chemical Biology and Therapeutics (CCBT), Bangalore,...
Global Red Biotechnology Market Growth Rate Opportunity, Segment by Regions and Forecast Till 2025...
The global market status for Red Biotechnology Market is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Red...
Snow algae thrive in high-elevation ice spires, an unlikely oasis for life
Credit: Steve Schmidt / University of Colorado Boulder
High in the Andes Mountains, dagger-shaped ice spires house thriving microbial communities, offering an oasis for life in one...
Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations
Phase III trial may change standard of care for up to 15% of colorectal cancer patients
Credit: MD Anderson Cancer Center
BARCELONA — The three-drug combination of encorafenib,...
Ludwig Cancer Research study discovers new cellular oxygen sensor
A Ludwig Cancer Research study led by Peter Ratcliffe and colleagues has discovered a previously overlooked oxygen sensor in animal cells that functions very much like one used by plants.
The ability of cells to...
First observation of native ferroelectric metal
tungsten ditelluride shows bistable and electrically switchable spontaneous polarization states; potential for new nano-electronics applications
Credit: FLEET
In a paper released today in Science Advances, UNSW researchers describe...
Acer Therapeutics Axes 60% of Workforce after FDA Rebuff
Acer Therapeutics said today it has eliminated about 60% of its workforce—29 jobs—and halted pre-commercialization activities for its lead candidate Edsivo (celiprolol) in a restructuring that comes two weeks after the FDA refused to...
Q&A: Evolution of CAR-T Cell Therapy and Future Directions
Sponsored content brought to you by
James Heath, PhD., is president and professor at the Institute for Systems Biology in Seattle. He also has the position of Professor of Molecular and Medical Pharmacology at UCLA,...
GENcast: A Biological GPS That Guides Awareness through Cellular Space
There’s no shame in contemplating how we managed to get around before GPS came to our phones. Some may argue that there is an overreliance on automation since maps have been a proven method...
